Enterovirus 71 viral capsid protein linear epitopes: Identification and characterization

Virology Journal

Volumn 9, Issue , 2012, Pages

  Gao, Fan ^a   Wang, Yi Ping ^b   Mao, Qun Ying ^a   Yao, Xin ^a   Liu, Shuang ^c   Li, Feng Xiang ^a   Zhu, Feng Cai ^d   Yang, Jing Yu ^b   Liang, Zheng Lun ^a   Lu, Feng Min ^e   Wang, Jun Zhi ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Capsid protein; Epitopes; EV71; Humoral immune response

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; VIRAL CAPSID PROTEIN; VIRUS PROTEIN; CAPSID PROTEIN; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MALE; NONHUMAN; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; VIRUS INACTIVATION; ANIMAL; BLOOD; ENTEROVIRUS; EPITOPE MAPPING; IMMUNOLOGY; INFANT; MIDDLE AGED; RABBIT;

HUMAN ENTEROVIRUS 71; MIRIDAE; ORYCTOLAGUS CUNICULUS;

ADULT; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHILD, PRESCHOOL; ENTEROVIRUS A, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MIDDLE AGED; RABBITS;

EID: 84856022095     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-26     Document Type: Article

References (23)

1. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C, Shih SR, Liu CC, Wu MH, Clin Infect Dis 2002 34 2 52 57 10.1086/338819 (Pubitemid 34442209)
2. Molecular epidemiology of enterovirus 71 over 2 decades in an Australian urban community. Sanders SA, Herrero LJ, McPHie K, Chow SS, Craig ME, Dwyer DE, Rawlinson W, McMinn PC, Arch Virol 2006 151 5 1003 1013 10.1007/s00705-005-0684- 9 16369861
3. Isolation of enterovirus 71 from patients with hand, foot and mouth disease in a local epidemic on March 2006, in Miyagi prefecture, Japan. Sato C, Syoji M, Ueki Y, Sato Y, Okimura Y, Saito N, Kikuchi N, Yagi T, Numakura H, Jpn J Infect Dis 2006 59 5 348 17060708 (Pubitemid 44650387)
4. Enterovirus 71 in Taiwan. Chang LY, Pediatr Neonatol 2008 49 4 103 112 10.1016/S1875-9572(08)60023-6 19054914
5. Emerging and re-emerging viruses in Malaysia, 1997-2007. Tee KK, Takebe Y, Kamarulzaman A, Int J Infect Dis 2009 13 3 307 318 10.1016/j.ijid.2008.09.005 19010076
6. Enterovirus 71 outbreak in the People's Republic of China in 2008. Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J, Clin Microbiol 2009 47 7 2351 2352 10.1128/JCM.00563-09
7. Epidemiology of hand, foot, and mouth disease and genotype characterization of enterovirus 71 in Jiangsu, China. Mao LX, Wu B, Bao WX, Han FA, Xu L, Ge QJ, Yang J, Yuan ZH, Miao CH, Huang XX, Zhang C, Xu H, J Clin Virol 2010 49 2 100 104 10.1016/j.jcv.2010.07.009 20719557
8. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB, J Clin Virol 2009 44 4 262 267 10.1016/j.jcv.2009.02.002 19269888
9. Enteroviruses as agents of emerging infectious diseases. Palacios G, Oberste MS, J Neurovirol 2005 11 5 424 433 10.1080/13550280591002531 16287683 (Pubitemid 43064681)
10. Jin Q, Medical Molecular Virology Beijing: Science Press 2001 606 613
11. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Foo DG, Alonso S, Chow VT, Poh CL, Microbes Infect 2007 9 11 1299 1306 10.1016/j.micinf.2007. 06.002 17890123 (Pubitemid 47539204)
12. High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Tan CS, Cardosa MJ, Arch Virol 2007 152 6 1069 1073 10.1007/s00705-007-0941-1 17318736 (Pubitemid 46800718)
13. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Foo DG, Alonso S, PHoon MC, Chow VT, Ramachandran NP, Poh CL, Virus Res 2007 125 1 61 68 10.1016/j.virusres.2006.12.005 17222936 (Pubitemid 46413387)
14. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS, Vaccine 2001 20 5-6 895 904 10.1016/S0264-410X(01)00385-1 11738755 (Pubitemid 34015831)
15. Genetic characteristic of enterovirus 71 complete genome isolated in Beijing, 2008. Yao X, Mao QY, Huang WJ, He P, Zhou C, Zhang W, Liang ZL, Li FX, Wang JZ, Zhonghua Liu Xing Bing Xue Za Zhi 2009 30 7 729 732 19957602
16. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. Xu F, Yan Q, Wang H, Niu J, Li L, Zhu FC, He SZ, Zhang SY, Weng ZX, Cheng T, Cai YJ, He DL, Chen YX, Ge SX, Yeo AET, Zhang J, Ng MH, Xia NS, PLoS One 2010 5 6 11388 10.1371/journal.pone.0011388 20613983
17. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Liang ZL, Mao QY, Gao Q, Li XL, Dong CH, Yu X, Yao X, Li FX, Yin WD, Li QH, Shen XL, Wang JZ, Vaccine 2011 29 52 9668 9674 10.1016/j.vaccine.2011.10. 018 22015395
18. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Li X, Mao C, Ma S, Wang X, Sun Z, Yi Y, Guo M, Shen X, Sun L, Bi S, Biochem Biophys Res Commun 2009 390 4 1126 1128 10.1016/j.bbrc.2009.09.103 19799860
19. Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. Miao LY, Pierce C, Gray-Johnson J, DeLotell J, Shaw C, Chapman N, Yeh E, Schnurr D, Huang YT, J Clin Microbiol 2009 47 10 3108 3113 10.1128/JCM.00479-09 19710278
20. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KHW, Sia C, Chong P, Vaccine 2011 29 4362 4372 10.1016/j.vaccine.2011.04.010 21501643
21. Identification of immunodominant VP1 linear epitope of enterovirus71(EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in western blots. Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL, Clin Microbiol Infect 2008 14 3 286 288 10.1111/j.1469-0691.2007.01904.x 18076666 (Pubitemid 351201022)
22. Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. Cello J, Samuelson A, Stålhandske P, Svennerholm B, Jeansson S, Forsgren M, J Clin Microbiol 1993 31 4 911 916 7681848 (Pubitemid 23086537)
23. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. Wang SY, Lin TL, Chen HY, Lin TS, J Virol Methods 2004 119 1 37 43 10.1016/j.jviromet.2004.02.017 15109819 (Pubitemid 38510525)